Rhumbline Advisers Idexx Laboratories Inc Transaction History

Rhumbline Advisers

$105 Billion
Q2 2024

A detailed history of Rhumbline Advisers transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Rhumbline Advisers holds 183,870 shares of IDXX stock, worth $79.6 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

183,870

Previous 179,155 2.63%

Holding current value

$79.6 Million

Previous $96.7 Million 7.39%

% of portfolio

0.09%

Previous 0.09%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	BUY	$468.04 - $548.53 $2.21 Million - $2.59 Million	4,715 Added 2.63%	183,870 $89.6 Million
Q1 2024 May 09, 2024	BUY	$515.08 - $576.87 $1.03 Million - $1.15 Million	1,993 Added 1.12%	179,155 $96.7 Million
Q4 2023 Feb 08, 2024	SELL	$391.37 - $557.56 $1.9 Million - $2.71 Million	-4,854 Reduced 2.67%	177,162 $98.3 Million
Q3 2023 Nov 09, 2023	BUY	$432.42 - $556.67 $808,625 - $1.04 Million	1,870 Added 1.04%	182,016 $79.6 Million
Q2 2023 Aug 08, 2023	BUY	$450.7 - $503.61 $1.62 Million - $1.81 Million	3,587 Added 2.03%	180,146 $90.5 Million
Q1 2023 May 11, 2023	BUY	$406.01 - $514.59 $4.79 Million - $6.07 Million	11,789 Added 7.15%	176,559 $88.3 Million
Q4 2022 Feb 14, 2023	BUY	$324.64 - $441.27 $2.76 Million - $3.76 Million	8,514 Added 5.45%	164,770 $67.2 Million
Q3 2022 Nov 10, 2022	BUY	$325.8 - $407.78 $220,240 - $275,659	676 Added 0.43%	156,256 $50.9 Million
Q2 2022 Aug 11, 2022	BUY	$327.37 - $553.44 $1.62 Million - $2.75 Million	4,961 Added 3.29%	155,580 $54.6 Million
Q1 2022 May 12, 2022	SELL	$466.52 - $631.01 $2.1 Million - $2.84 Million	-4,508 Reduced 2.91%	150,619 $82.4 Million
Q4 2021 Feb 10, 2022	SELL	$586.54 - $666.48 $1.49 Million - $1.7 Million	-2,544 Reduced 1.61%	155,127 $102 Million
Q3 2021 Nov 12, 2021	BUY	$621.9 - $705.76 $2.99 Million - $3.39 Million	4,801 Added 3.14%	157,671 $98.1 Million
Q2 2021 Aug 05, 2021	SELL	$486.36 - $637.08 $2.09 Million - $2.74 Million	-4,299 Reduced 2.74%	152,870 $96.5 Million
Q1 2021 May 06, 2021	SELL	$465.18 - $551.79 $5.03 Million - $5.97 Million	-10,822 Reduced 6.44%	157,169 $76.9 Million
Q4 2020 Feb 10, 2021	SELL	$383.85 - $499.87 $2.12 Million - $2.76 Million	-5,529 Reduced 3.19%	167,991 $84 Million
Q3 2020 Nov 12, 2020	SELL	$334.54 - $406.31 $1.49 Million - $1.81 Million	-4,455 Reduced 2.5%	173,520 $68.2 Million
Q2 2020 Aug 13, 2020	BUY	$230.66 - $330.16 $332,150 - $475,430	1,440 Added 0.82%	177,975 $58.8 Million
Q1 2020 May 06, 2020	BUY	$182.94 - $290.97 $146,900 - $233,648	803 Added 0.46%	176,535 $42.8 Million
Q4 2019 Feb 05, 2020	BUY	$248.66 - $285.01 $1.2 Million - $1.38 Million	4,833 Added 2.83%	175,732 $45.9 Million
Q3 2019 Oct 23, 2019	BUY	$260.07 - $289.93 $29,908 - $33,341	115 Added 0.07%	170,899 $46.5 Million
Q2 2019 Aug 14, 2019	SELL	$215.53 - $275.33 $811,039 - $1.04 Million	-3,763 Reduced 2.16%	170,784 $47 Million
Q1 2019 May 01, 2019	SELL	$178.02 - $225.69 $867,135 - $1.1 Million	-4,871 Reduced 2.71%	174,547 $39 Million
Q4 2018 Jan 31, 2019	SELL	$176.18 - $248.92 $783,472 - $1.11 Million	-4,447 Reduced 2.42%	179,418 $33.4 Million
Q3 2018 Nov 07, 2018	SELL	$218.82 - $254.46 $1.23 Million - $1.42 Million	-5,600 Reduced 2.96%	183,865 $45.9 Million
Q2 2018 Aug 06, 2018	BUY	$185.56 - $227.9 $796,423 - $978,146	4,292 Added 2.32%	189,465 $41.3 Million
Q1 2018 May 02, 2018	SELL	$157.81 - $204.73 $509,252 - $660,663	-3,227 Reduced 1.71%	185,173 $35.4 Million
Q4 2017 Feb 09, 2018	BUY	$147.68 - $168.37 $48,143 - $54,888	326 Added 0.17%	188,400 $29.5 Million
Q3 2017 Nov 06, 2017	BUY	$150.32 - $166.46 $28.3 Million - $31.3 Million	188,074	188,074 $29.2 Million

Others Institutions Holding IDXX

# of Institutions

1,204

Shares Held

76.1M

Call Options Held

176K

Put Options Held

283K

View Full List

About IDEXX LABORATORIES INC

Ticker IDXX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 83,253,696
Market Cap $36B
Description
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...

More about IDXX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Idexx Laboratories Inc Transaction History